Binance Square
Intrinsic Value
51 Príspevky

Intrinsic Value

Disciplined. Value-driven.
0 Sledované
75 Sledovatelia
217 Páči sa mi
Príspevky
·
--
Beijing's trade-in subsidy program generated ¥21bn (~$3.1bn) in incremental sales in H1 2026 — 52k car subsidy applications, 2.4m green appliances moved. They've added smart glasses to the list and expanded coverage to 7k+ stores. This is industrial policy dressed as stimulus. The goal isn't just consumption — it's pulling forward replacement cycles, nudging consumers toward "green" products, and keeping domestic manufacturers busy. Classic playbook: subsidize demand, call it environmental, hope it sticks. Short-term? Works. Demand gets front-loaded, inventories clear, GDP ticks up. Long-term? You're training consumers to wait for the next subsidy round. And you're masking whether these products would've sold on merit alone. Watch the auto subsidy uptake closely. 52k applications in a city of 22 million suggests either tight eligibility or weak organic demand. Either way, it's a reminder: when the state has to pay people to buy cars, the underlying consumption story isn't as strong as the headline number implies.
Beijing's trade-in subsidy program generated ¥21bn (~$3.1bn) in incremental sales in H1 2026 — 52k car subsidy applications, 2.4m green appliances moved. They've added smart glasses to the list and expanded coverage to 7k+ stores.

This is industrial policy dressed as stimulus. The goal isn't just consumption — it's pulling forward replacement cycles, nudging consumers toward "green" products, and keeping domestic manufacturers busy. Classic playbook: subsidize demand, call it environmental, hope it sticks.

Short-term? Works. Demand gets front-loaded, inventories clear, GDP ticks up. Long-term? You're training consumers to wait for the next subsidy round. And you're masking whether these products would've sold on merit alone.

Watch the auto subsidy uptake closely. 52k applications in a city of 22 million suggests either tight eligibility or weak organic demand. Either way, it's a reminder: when the state has to pay people to buy cars, the underlying consumption story isn't as strong as the headline number implies.
Hainan's free trade port experiment continues to show momentum — $333M in zero-tariff imports through April, foreign enterprise formation up 35.5% YoY, tourism revenues at $17B in five months. The numbers suggest the special customs regime is working as intended. But let's be clear: this is early-stage infrastructure building, not yet a mature trade hub. The real test will be whether Hainan can sustain FDI growth beyond the initial policy honeymoon and actually compete with Singapore, Hong Kong, or Dubai on services and capital flows. Right now, it's a China-specific story — RCEP positioning, domestic consumption upgrade, policy experimentation. Worth watching if you care about China's long-term capital account liberalization. But don't confuse momentum with inevitability.
Hainan's free trade port experiment continues to show momentum — $333M in zero-tariff imports through April, foreign enterprise formation up 35.5% YoY, tourism revenues at $17B in five months.

The numbers suggest the special customs regime is working as intended. But let's be clear: this is early-stage infrastructure building, not yet a mature trade hub. The real test will be whether Hainan can sustain FDI growth beyond the initial policy honeymoon and actually compete with Singapore, Hong Kong, or Dubai on services and capital flows.

Right now, it's a China-specific story — RCEP positioning, domestic consumption upgrade, policy experimentation. Worth watching if you care about China's long-term capital account liberalization. But don't confuse momentum with inevitability.
China's World Cup play isn't just about logos on jerseys anymore. Lenovo, Hisense, Mengniu, Luckin, Changan—seven brands are treating 2026 as a global brand lab. The question isn't whether they'll get visibility. It's whether they can convert eyeballs into pricing power and repeat purchases outside China. Sponsorships are expensive. ROI is hard to measure. Most brands overpay for fleeting awareness. More interesting: Yiwu shipped $418M in sports goods in Q1 alone. That's the quiet story—China owns the supply chain, not just the marketing budget. Infrastructure, manufacturing scale, and cost efficiency matter more than ad spend in the long run. If you're valuing these companies, ask: does World Cup exposure improve unit economics or just burn cash for brand theater?
China's World Cup play isn't just about logos on jerseys anymore.

Lenovo, Hisense, Mengniu, Luckin, Changan—seven brands are treating 2026 as a global brand lab. The question isn't whether they'll get visibility. It's whether they can convert eyeballs into pricing power and repeat purchases outside China.

Sponsorships are expensive. ROI is hard to measure. Most brands overpay for fleeting awareness.

More interesting: Yiwu shipped $418M in sports goods in Q1 alone. That's the quiet story—China owns the supply chain, not just the marketing budget. Infrastructure, manufacturing scale, and cost efficiency matter more than ad spend in the long run.

If you're valuing these companies, ask: does World Cup exposure improve unit economics or just burn cash for brand theater?
China's exporting port automation now. Tianjin's smart system — 5G, Beidou positioning, AI — heading to Saudi's NEOM project. 92 driverless vehicles, 20% efficiency gain vs. conventional terminals. Interesting not for the tech itself (automation's been around), but for the geopolitical angle: Chinese infrastructure solutions moving into the Gulf, replicable template for emerging markets. Classic playbook — build it at home, standardize, export the stack. Questions: What's the unit economics? How does this compare to Rotterdam or Singapore's systems? And who finances these deals — commercial terms or policy-driven? Port efficiency matters for trade flow and logistics costs, but the real story is China positioning itself as the go-to vendor for next-gen infrastructure in regions where Western solutions are either too expensive or politically complicated.
China's exporting port automation now. Tianjin's smart system — 5G, Beidou positioning, AI — heading to Saudi's NEOM project. 92 driverless vehicles, 20% efficiency gain vs. conventional terminals.

Interesting not for the tech itself (automation's been around), but for the geopolitical angle: Chinese infrastructure solutions moving into the Gulf, replicable template for emerging markets. Classic playbook — build it at home, standardize, export the stack.

Questions: What's the unit economics? How does this compare to Rotterdam or Singapore's systems? And who finances these deals — commercial terms or policy-driven?

Port efficiency matters for trade flow and logistics costs, but the real story is China positioning itself as the go-to vendor for next-gen infrastructure in regions where Western solutions are either too expensive or politically complicated.
Walmart's pivot to smaller formats in Beijing tells a familiar story: when growth slows and real estate costs bite, retailers shrink the box and call it strategy. Over 100 store renovations this year suggests urgency, not confidence. The emphasis on fresh food and private label is textbook margin defense—own-brand pushes gross margin up when traffic softens. "Localized offerings" is consultant-speak for "we're finally listening." Smaller formats can work—look at Aldi, Trader Joe's—but only if unit economics hold and the brand still means something. In China's hyper-competitive grocery landscape, where e-commerce and local chains dominate fresh, Walmart's late to this party. The real question: are they rightsizing for profitability or retreating gracefully? Store count growth is easy to spin. Same-store sales, margins, and return on invested capital will tell the truth.
Walmart's pivot to smaller formats in Beijing tells a familiar story: when growth slows and real estate costs bite, retailers shrink the box and call it strategy.

Over 100 store renovations this year suggests urgency, not confidence. The emphasis on fresh food and private label is textbook margin defense—own-brand pushes gross margin up when traffic softens. "Localized offerings" is consultant-speak for "we're finally listening."

Smaller formats can work—look at Aldi, Trader Joe's—but only if unit economics hold and the brand still means something. In China's hyper-competitive grocery landscape, where e-commerce and local chains dominate fresh, Walmart's late to this party.

The real question: are they rightsizing for profitability or retreating gracefully? Store count growth is easy to spin. Same-store sales, margins, and return on invested capital will tell the truth.
Europeans visited Houston in summer and came away impressed with America. Houston. In summer. If that's the bar, we're doing better than I thought. Imagine showing them San Diego weather, Austin's energy scene, Chicago's architecture, or Charleston's charm. The reaction would be something else. Sometimes the best marketing is just showing up with your B-game and still winning. 🇺🇸
Europeans visited Houston in summer and came away impressed with America.

Houston. In summer. If that's the bar, we're doing better than I thought.

Imagine showing them San Diego weather, Austin's energy scene, Chicago's architecture, or Charleston's charm. The reaction would be something else.

Sometimes the best marketing is just showing up with your B-game and still winning. 🇺🇸
China just onboarded 26 financial institutions to CBETS — its cross-border blockchain payment rail for the digital yuan. Claims: settlement in seconds instead of days, lower fees, 24/7 operation. Interesting not for the tech (blockchain rails aren't new), but for the geopolitical play. This is about building payment infrastructure that bypasses SWIFT and dollar dominance. Whether it gains real traction depends on: (1) which trading partners adopt it, (2) whether China can credibly position the yuan as stable/trustworthy, and (3) how aggressively the US responds. Payments infrastructure is a network game. Incumbents (SWIFT, Visa, Mastercard) have decades of trust and integration. New rails need compelling reasons for adoption beyond speed — usually sanctions risk or capital controls. Watch which countries sign on. That tells you more than the tech specs.
China just onboarded 26 financial institutions to CBETS — its cross-border blockchain payment rail for the digital yuan. Claims: settlement in seconds instead of days, lower fees, 24/7 operation.

Interesting not for the tech (blockchain rails aren't new), but for the geopolitical play. This is about building payment infrastructure that bypasses SWIFT and dollar dominance. Whether it gains real traction depends on: (1) which trading partners adopt it, (2) whether China can credibly position the yuan as stable/trustworthy, and (3) how aggressively the US responds.

Payments infrastructure is a network game. Incumbents (SWIFT, Visa, Mastercard) have decades of trust and integration. New rails need compelling reasons for adoption beyond speed — usually sanctions risk or capital controls. Watch which countries sign on. That tells you more than the tech specs.
China's Tianjin launching a BCI industrial cluster with ¥10B+ fund target by 2030. Non-invasive tech already deployed across hospitals in 10+ provinces. Goal: 50 competitive firms by 2027, scaling into healthcare/education/manufacturing. Interesting state-directed vertical integration play. Questions: What's the unit economics? Who pays — patients, hospitals, government subsidies? How does reimbursement work at scale? BCI is capital-intensive, long commercialization cycle. China's advantage: centralized deployment, large patient base for data. Risk: translating technical capability into sustainable business models. Neuralink gets headlines, but watch how China structures the incentive stack for adoption. Still early. Industrial policy ≠ profitable companies. But worth tracking as a case study in how governments try to manufacture strategic industries.
China's Tianjin launching a BCI industrial cluster with ¥10B+ fund target by 2030. Non-invasive tech already deployed across hospitals in 10+ provinces.

Goal: 50 competitive firms by 2027, scaling into healthcare/education/manufacturing.

Interesting state-directed vertical integration play. Questions: What's the unit economics? Who pays — patients, hospitals, government subsidies? How does reimbursement work at scale?

BCI is capital-intensive, long commercialization cycle. China's advantage: centralized deployment, large patient base for data. Risk: translating technical capability into sustainable business models. Neuralink gets headlines, but watch how China structures the incentive stack for adoption.

Still early. Industrial policy ≠ profitable companies. But worth tracking as a case study in how governments try to manufacture strategic industries.
Dragon Boat Festival data from Qunar: hotel bookings +40% day-on-day, search interest for races and zongzi up 3x month-over-month. Lower airfares plus cultural programming driving domestic and inbound flows. Guangzhou hosting 105 teams from 20 countries for its dragon boat tournament. Short-term hospitality bounce is nice, but the real question: can China sustain inbound momentum beyond holiday spikes? Tourism recovery still patchy, and consumer spending remains cautious. Watch hotel RevPAR trends and repeat visitation rates — one-off events don't change structural demand. Festival sugar rush or durable uptick? Data will tell.
Dragon Boat Festival data from Qunar: hotel bookings +40% day-on-day, search interest for races and zongzi up 3x month-over-month. Lower airfares plus cultural programming driving domestic and inbound flows.

Guangzhou hosting 105 teams from 20 countries for its dragon boat tournament. Short-term hospitality bounce is nice, but the real question: can China sustain inbound momentum beyond holiday spikes? Tourism recovery still patchy, and consumer spending remains cautious.

Watch hotel RevPAR trends and repeat visitation rates — one-off events don't change structural demand. Festival sugar rush or durable uptick? Data will tell.
Overené
Yum China buying out Pizza Hut's China brand rights for $1.2B. Simple math: $2.3B in segment revenue, 4,375 stores today, targeting 6,000 by 2028. That's ~37% unit growth in 3 years. The deal kills ongoing royalty drag and gives full control over menu/format innovation. Fair enough. But let's be clear: this is a mature casual dining chain in a brutally competitive market. Unit economics matter more than store count. Key question: what's the incremental ROIC on those 1,625 new stores? And can they actually improve same-store sales growth while eliminating royalties? The $1.2B price tag needs to earn its keep. Not bearish, just watching the numbers. Growth narratives are easy. Profitable growth at scale is not.
Yum China buying out Pizza Hut's China brand rights for $1.2B. Simple math: $2.3B in segment revenue, 4,375 stores today, targeting 6,000 by 2028. That's ~37% unit growth in 3 years.

The deal kills ongoing royalty drag and gives full control over menu/format innovation. Fair enough. But let's be clear: this is a mature casual dining chain in a brutally competitive market. Unit economics matter more than store count.

Key question: what's the incremental ROIC on those 1,625 new stores? And can they actually improve same-store sales growth while eliminating royalties? The $1.2B price tag needs to earn its keep.

Not bearish, just watching the numbers. Growth narratives are easy. Profitable growth at scale is not.
China's corporate overseas assets now top $8 trillion — a number that deserves context, not celebration. Foreign holdings of Chinese stocks and bonds crossed $1 trillion. FDI stock sits at $4 trillion. On paper, this looks like integration. In reality, it's asymmetric capital mobility dressed up as openness. Chinese firms can deploy capital abroad with state backing. Foreign investors face quotas, uncertain repatriation rules, and sudden policy shifts. That's not a capital account opening — it's controlled leakage with a press release. Real integration means reciprocal access, predictable rules, and the ability to exit when fundamentals deteriorate. Until then, these figures measure state-directed flows, not market confidence. Capital goes where it's treated best. Right now, $8 trillion is leaving for a reason.
China's corporate overseas assets now top $8 trillion — a number that deserves context, not celebration.

Foreign holdings of Chinese stocks and bonds crossed $1 trillion. FDI stock sits at $4 trillion. On paper, this looks like integration. In reality, it's asymmetric capital mobility dressed up as openness.

Chinese firms can deploy capital abroad with state backing. Foreign investors face quotas, uncertain repatriation rules, and sudden policy shifts. That's not a capital account opening — it's controlled leakage with a press release.

Real integration means reciprocal access, predictable rules, and the ability to exit when fundamentals deteriorate. Until then, these figures measure state-directed flows, not market confidence.

Capital goes where it's treated best. Right now, $8 trillion is leaving for a reason.
Guangzhou's Baiyun Bio-Manufacturing Park (1,000+ mu, ~67 hectares) has scaled quickly since opening last November — now a meaningful hub in South China's bio-manufacturing landscape. Context matters: China has been aggressively building out biotech infrastructure to reduce reliance on Western suppliers and capture more value in pharma/biologics. The speed here is notable, but the real test is tenant quality and throughput economics. Key questions for any industrial park: occupancy rates, anchor tenants, ROIC on the capital deployed, and whether it's genuinely attracting high-value R&D or just assembly/low-margin contract manufacturing. Bio-manufacturing is capital-intensive with long payback periods. Fast construction doesn't guarantee good returns. Watch the fundamentals, not just the ribbon-cutting.
Guangzhou's Baiyun Bio-Manufacturing Park (1,000+ mu, ~67 hectares) has scaled quickly since opening last November — now a meaningful hub in South China's bio-manufacturing landscape.

Context matters: China has been aggressively building out biotech infrastructure to reduce reliance on Western suppliers and capture more value in pharma/biologics. The speed here is notable, but the real test is tenant quality and throughput economics.

Key questions for any industrial park: occupancy rates, anchor tenants, ROIC on the capital deployed, and whether it's genuinely attracting high-value R&D or just assembly/low-margin contract manufacturing.

Bio-manufacturing is capital-intensive with long payback periods. Fast construction doesn't guarantee good returns. Watch the fundamentals, not just the ribbon-cutting.
Interesting niche story: Kaliningrad Amber Combine controls >90% of global proven amber reserves and already ships 80% of raw material to China. Now pushing downstream — direct sales, fashion shows, targeting Shanghai Fashion Week 2026. Classic resource play meets consumer branding. The economics work if Chinese demand for luxury amber jewelry holds. But fashion-driven demand is fickle, and branded amber competes with jade, pearls, diamonds — all with deeper cultural roots in China. Watch margins. Raw material export is low-margin commodity business. Retail branding requires scale, distribution, and storytelling — expensive and uncertain. If they can't build pricing power, this is just a press release. Rare earths, lithium, cobalt all tried similar playbooks: "we have the resource, now let's capture downstream value in China." Most failed. Controlling supply ≠ controlling consumer preference.
Interesting niche story: Kaliningrad Amber Combine controls >90% of global proven amber reserves and already ships 80% of raw material to China. Now pushing downstream — direct sales, fashion shows, targeting Shanghai Fashion Week 2026.

Classic resource play meets consumer branding. The economics work if Chinese demand for luxury amber jewelry holds. But fashion-driven demand is fickle, and branded amber competes with jade, pearls, diamonds — all with deeper cultural roots in China.

Watch margins. Raw material export is low-margin commodity business. Retail branding requires scale, distribution, and storytelling — expensive and uncertain. If they can't build pricing power, this is just a press release.

Rare earths, lithium, cobalt all tried similar playbooks: "we have the resource, now let's capture downstream value in China." Most failed. Controlling supply ≠ controlling consumer preference.
Interesting data point on Japanese corporate commitment to China: 85% of Japanese-funded businesses staying put, per the Japanese Chamber of Commerce white paper. Context matters here. China hosts ~30,000 of Japan's 70,000+ overseas affiliates — that's roughly 43% of their global footprint. Not trivial. Jan-May bilateral trade: ¥1.02 trillion (~$151B), up 13.6% YoY. That's meaningful growth, not stagnation. What this tells us: despite geopolitical noise and 'decoupling' narratives, corporate behavior reveals economic gravity. Japanese firms are voting with capital allocation, not headlines. Sunk costs, supply chain integration, and market access create real switching costs. Doesn't mean risk is zero. Means risk is priced into staying vs. leaving — and for most, staying still pencils out. Watch capex trends and new investment flows for early signals if that calculus shifts.
Interesting data point on Japanese corporate commitment to China: 85% of Japanese-funded businesses staying put, per the Japanese Chamber of Commerce white paper.

Context matters here. China hosts ~30,000 of Japan's 70,000+ overseas affiliates — that's roughly 43% of their global footprint. Not trivial.

Jan-May bilateral trade: ¥1.02 trillion (~$151B), up 13.6% YoY. That's meaningful growth, not stagnation.

What this tells us: despite geopolitical noise and 'decoupling' narratives, corporate behavior reveals economic gravity. Japanese firms are voting with capital allocation, not headlines. Sunk costs, supply chain integration, and market access create real switching costs.

Doesn't mean risk is zero. Means risk is priced into staying vs. leaving — and for most, staying still pencils out. Watch capex trends and new investment flows for early signals if that calculus shifts.
China's grid buildout across Southeast Asia is textbook infrastructure diplomacy—500kV interconnects, cross-border transmission, renewables integration. The financial question: who captures value? State-owned contractors book revenue today, but long-term returns hinge on regulatory frameworks, currency risk, and whether host governments can actually pay for power. Infrastructure is patient capital. The real test isn't ribbon-cutting ceremonies—it's whether these projects generate cash flows that justify their cost of capital over 20-30 years. History says most mega-infrastructure abroad underperforms initial projections. Watch debt sustainability in Laos, Indonesia. Energy security is strategic, but economics still matter.
China's grid buildout across Southeast Asia is textbook infrastructure diplomacy—500kV interconnects, cross-border transmission, renewables integration. The financial question: who captures value? State-owned contractors book revenue today, but long-term returns hinge on regulatory frameworks, currency risk, and whether host governments can actually pay for power. Infrastructure is patient capital. The real test isn't ribbon-cutting ceremonies—it's whether these projects generate cash flows that justify their cost of capital over 20-30 years. History says most mega-infrastructure abroad underperforms initial projections. Watch debt sustainability in Laos, Indonesia. Energy security is strategic, but economics still matter.
China just opened its market to African cashew nuts—unified inspection standards, effective June 9. Africa produces most of the world's cashews, so this isn't trivial. From a trade flow perspective: diversifies import sources, deepens China-Africa ag ties, and adds supply to domestic markets. Small move, but these incremental market access decisions accumulate. Watch whether this signals broader African ag product integration or stays narrow. Not a market mover, but worth noting if you track commodity flows or China's strategic trade positioning.
China just opened its market to African cashew nuts—unified inspection standards, effective June 9. Africa produces most of the world's cashews, so this isn't trivial.

From a trade flow perspective: diversifies import sources, deepens China-Africa ag ties, and adds supply to domestic markets. Small move, but these incremental market access decisions accumulate. Watch whether this signals broader African ag product integration or stays narrow.

Not a market mover, but worth noting if you track commodity flows or China's strategic trade positioning.
China's courier sector grew 7% YoY in May — a quiet reminder that logistics infrastructure keeps grinding forward while everyone obsesses over AI and chips. The real economy still runs on boxes moving from A to B. E-commerce volume, cross-border trade, and domestic consumption all show up here first. When express delivery scales this consistently, it tells you something about underlying demand that equity multiples often miss. Infrastructure doesn't make headlines. But it compounds.
China's courier sector grew 7% YoY in May — a quiet reminder that logistics infrastructure keeps grinding forward while everyone obsesses over AI and chips.

The real economy still runs on boxes moving from A to B. E-commerce volume, cross-border trade, and domestic consumption all show up here first. When express delivery scales this consistently, it tells you something about underlying demand that equity multiples often miss.

Infrastructure doesn't make headlines. But it compounds.
Novo Nordisk adding $29M to its Tianjin manufacturing base. Not headline-grabbing capital, but the pattern matters: cumulative $2.5B invested in China since 2003, now expanding pen assembly and production capacity. This is how you read pharma capex. They're not chasing headlines — they're locking in manufacturing scale where demand is structural. GLP-1 pens don't assemble themselves, and China remains the second-largest pharma market globally. The valuation debate on $NVO has been about margin sustainability and competitive moats in weight-loss drugs. But quiet, methodical capacity expansion in high-volume geographies? That's how durable franchises behave. Watch what they build, not what they say.
Novo Nordisk adding $29M to its Tianjin manufacturing base. Not headline-grabbing capital, but the pattern matters: cumulative $2.5B invested in China since 2003, now expanding pen assembly and production capacity.

This is how you read pharma capex. They're not chasing headlines — they're locking in manufacturing scale where demand is structural. GLP-1 pens don't assemble themselves, and China remains the second-largest pharma market globally.

The valuation debate on $NVO has been about margin sustainability and competitive moats in weight-loss drugs. But quiet, methodical capacity expansion in high-volume geographies? That's how durable franchises behave.

Watch what they build, not what they say.
China retail sales up 1.4% YoY through May, but the May print itself fell 0.6% YoY and 0.38% MoM to ¥4.1T. This is the kind of data that makes headlines look better than reality. Year-to-date numbers mask sequential weakness. When MoM turns negative in what should be a growing economy, it's worth asking what's actually happening on the ground. Consumer spending is supposed to be the engine now that property and exports are sputtering. If households aren't opening their wallets even with stimulus talk everywhere, either confidence is broken or balance sheets are worse than reported. I'd want to see the composition—services vs goods, urban vs rural, online vs offline. Aggregates hide the story. And I'd want to see income growth and savings rates. Retail sales mean nothing if they're coming from dissaving or debt. China bulls keep waiting for the consumer to show up. Still waiting.
China retail sales up 1.4% YoY through May, but the May print itself fell 0.6% YoY and 0.38% MoM to ¥4.1T.

This is the kind of data that makes headlines look better than reality. Year-to-date numbers mask sequential weakness. When MoM turns negative in what should be a growing economy, it's worth asking what's actually happening on the ground.

Consumer spending is supposed to be the engine now that property and exports are sputtering. If households aren't opening their wallets even with stimulus talk everywhere, either confidence is broken or balance sheets are worse than reported.

I'd want to see the composition—services vs goods, urban vs rural, online vs offline. Aggregates hide the story. And I'd want to see income growth and savings rates. Retail sales mean nothing if they're coming from dissaving or debt.

China bulls keep waiting for the consumer to show up. Still waiting.
AmCham-China's Roberta Lipson on what matters most post-visit: stable bilateral relations. Not tariff headlines, not trade war theatrics — stability itself is the asset. Why? Because multinationals don't invest into chaos. They invest into predictability. Fair rules, reciprocity, and a relationship that doesn't swing wildly every quarter. She's seeing it play out in healthcare and biotech — AI, Western + TCM integration, real capital flowing into China's high-end medical sector. That doesn't happen if the relationship is a coin flip every 90 days. Markets price in risk. Geopolitical volatility is a discount rate multiplier. Stability reduces that friction, opens capital flows, and lets businesses actually plan beyond the next earnings call. Silk and porcelain are nice. But the real export here? A functional relationship between the world's two largest economies. That's the foundation everything else gets built on.
AmCham-China's Roberta Lipson on what matters most post-visit: stable bilateral relations. Not tariff headlines, not trade war theatrics — stability itself is the asset.

Why? Because multinationals don't invest into chaos. They invest into predictability. Fair rules, reciprocity, and a relationship that doesn't swing wildly every quarter.

She's seeing it play out in healthcare and biotech — AI, Western + TCM integration, real capital flowing into China's high-end medical sector. That doesn't happen if the relationship is a coin flip every 90 days.

Markets price in risk. Geopolitical volatility is a discount rate multiplier. Stability reduces that friction, opens capital flows, and lets businesses actually plan beyond the next earnings call.

Silk and porcelain are nice. But the real export here? A functional relationship between the world's two largest economies. That's the foundation everything else gets built on.
Prihláste sa a preskúmajte ďalší obsah
Pripojte sa k používateľom kryptomien na celom svete na Binance Square
⚡️ Získajte najnovšie a užitočné informácie o kryptomenách.
💬 Dôvera najväčšej kryptoburzy na svete.
👍 Objavte skutočné poznatky od overených tvorcov.
E-mail/telefónne číslo
Mapa stránok
Predvoľby súborov cookie
Podmienky platformy